Real-time data

Listing exchange

NASDAQ Stock Exchange

Price

$14.05

Day High

$14.1

Day Low

$13.62

Day Open

$14.05

Volume

17635

Day Change

2.21%

Latest news data for ACRS

Aclaris Therapeutics (ACRS) Presents at the 41st Annual J.P. Morgan Healthcare Conference -- Slideshow (NASDAQ:ACRS)

Transcript : Aclaris Therapeutics, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-11-2023 02:15 PM

Aclaris Therapeutics Has Strong Upside Potential, But Shares Could Be Lower (NASDAQ:ACRS)

Aclaris Therapeutics Provides 2023 Outlook

Common Warts Market Value to reach US$ 1,100 Million by 2033; Salicylic Acid-based Drugs to be Most Consumed: Future Market Insights, Inc. Study

Aclaris Therapeutics, Inc. : Goldman Sachs maintient sa recommandation ?'achat

Aclaris Therapeutics and Pediatrix Therapeutics Announce License Agreement for ATI-1777 in Greater China

Seborrheic Keratosis Treatment Size to Grow by USD 786.38 Mn, Cryotherapy to be Largest Revenue-generating Application Segment - Technavio

Insider Selling: Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Director Sells $248,618.16 in Stock

Aclaris Therapeutics (NASDAQ:ACRS) Stock Price Down 8.7% Following Insider Selling

News sentiment (24 hrs)

Intraday data

Historical data

maximum of 5 years displayed, 40+ years of data available via API